You are here

Latest news & updates

7 October 2021
Australian Public Assessment Report for Eslicarbazepine acetate
6 October 2021
GMDN guidance is to assist sponsors and manufacturers when applying for inclusion in the ARTG and selecting a GMDN term.
5 October 2021
On 1 October 2021, the TGA granted provisional determination to Pfizer Australia in relation to a new combination medicine containing PF-07321332 and ritonavir, for the treatment of adult patients with symptomatic, confirmed coronavirus infection.
5 October 2021
2020/21 Therapeutic Goods Advertising Compliance Annual Report has been published
5 October 2021
This fact sheet explains how sponsors and advertisers of therapeutic goods can lawfully include statements about COVID-19 testing in their advertising.
1 October 2021
Australian consumers now require a valid prescription from any of Australia's 100,000 medical practitioners to import nicotine vaping products, purchased from overseas websites.
30 September 2021
Presentation from TGA Lecture at Biomedical engineering Department
30 September 2021
Australian Public Assessment Report for Fluticasone furoate / umeclidinium / vilanterol
30 September 2021
HealthHub247 Pty Ltd (HealthHub247) and its Director have been convicted of the unlawful manufacture, counterfeit, advertising and supply of sports supplements that contain prohibited substances in the current Poisons Standard.
30 September 2021
Interim decisions and invitation for further comment. Closing date: 1 November 2021


Subscribe to Latest news & updates